Faculty, Staff and Student Publications
Language
English
Publication Date
8-1-2025
Journal
Leukemia
DOI
10.1038/s41375-025-02664-w
PMID
40646132
PMCID
PMC12310532
PubMedCentral® Posted Date
7-11-2025
PubMedCentral® Full Text Version
Post-print
Abstract
In this 5th version of the European LeukemiaNet guidance for adult patients, there are important changes in several areas of management based on evidence available since 2020, including the World Health Organisation's reclassification of CML as a biphasic disease. Previous advice to switch the tyrosine kinase inhibitor (TKI) on failure of molecular milestones, is modified to better account for individual patient circumstances. Our recommendations are summarized in tables designed to be read in conjunction with the text which offers justification and additional advice. We describe decision-making for first-line treatment, both in available drugs and their initial dosing. Similarly we elaborate on dose reduction rather than drug switching to manage toxicities and discuss treatment sequencing. Data have matured for the outcome of treatment discontinuation and for management of parenting for both men and women. We acknowledge that most patients will remain on treatment for many years and emphasize the needs to minimize side effects, manage co-morbidities and optimize quality of life. Recent advances in allogeneic stem cell transplantation have broadened access to alternative donors, and lessened limitations of age and co-morbidities such that transplant remains a valuable option for patients for whom long-term disease control is not achieved through TKI therapy.
Keywords
Humans, Disease Management, Europe, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Protein Kinase Inhibitors, Molecularly targeted therapy, Health care
Published Open-Access
yes
Recommended Citation
Apperley, Jane F; Milojkovic, Dragana; Cross, Nicholas C P; et al., "2025 European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia" (2025). Faculty, Staff and Student Publications. 5484.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5484
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons